Oxford BioMedica (UK) Limited
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Oxford ranks #27,063 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.
- #27,063
- of 49,997 US assignees by volume
- 46th percentile
- by Innovation Score (33.8/100)
- 15.9
- avg claims per patent
- -20%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R27063 · Foreign Corporation #27,063 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #27,063/49,997
- PHOTO-FINISH Opla Energy
- CPC-NARROW C12N · 7 areas
- INNOV-THIN 33.8/100
- CLAIMS-RICH 15.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -20% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Opla Energy Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Oxford’s 33.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Oxford
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Oxford BioMedica (UK) · this assignee 34
Oxford BioMedica (UK) · this assignee
34 score
- Shenzhen Intellifusion · near 34
Shenzhen Intellifusion · near
34 score
- SMed-TA/TD · near 34
SMed-TA/TD · near
34 score
- Wein Holding · near 34
Wein Holding · near
34 score
- Zwipe AS · near 34
Zwipe AS · near
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Oxford's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Oxford?
Each dot is one of Oxford’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oxford’s own 15.9 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Oxford's grants concentrate
Oxford BioMedica (UK) Limited is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Oxford sits between Opla Energy Ltd. and Panasonic Corporation OF North America.
Oxford's three-year grant acceleration
Oxford BioMedica (UK) Limited shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Oxford's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Opla Energy
Opla Energy Ltd.
10 patents
- Optibiotix
Optibiotix Limited
10 patents
- Orlandi
Orlandi, Inc.
10 patents
- Out of Sight Visi…
Out of Sight Vision Systems LLC
10 patents
- Oxford Instrument…
Oxford Instruments AFM Inc
10 patents
- Oxiteno Indústria…
Oxiteno S.A. Indústria e Comércio
10 patents
- Palobiofarma S L
Palobiofarma, S.L.
10 patents
- Panasonic OF Nort…
Panasonic Corporation OF North America
10 patents
- Oxford Biomedica… ◀
Oxford BioMedica (UK) Limited
10 patents
What this shows Oxford holds 10 patents at rank #27,054, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Oxford
By rank, the assignees closest to #27,054 in granted patent volume.
- Opla Energy Ltd. #27,050 · 10 patents
- Optibiotix Limited #27,051 · 10 patents
- Orlandi, Inc. #27,052 · 10 patents
- Out of Sight Vision Systems LLC #27,053 · 10 patents
- Oxford Instruments AFM Inc #27,055 · 10 patents
- Oxiteno S.A. Indústria e Comércio #27,056 · 10 patents
- Palobiofarma, S.L. #27,057 · 10 patents
- Panasonic Corporation OF North America #27,058 · 10 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Oxford's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Oxford, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Oxford ranks #1,018 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (34 here).
Oxford's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 46th percentile higher than 46% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 10.0% |
| 2016 | 1 | 10.0% |
| 2017 | 1 | 10.0% |
| 2019 | 2 | 20.0% |
| 2020 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2024 | 1 | 10.0% |
| 2025partial year | 1 | 10.0% |
Which technologies does Oxford BioMedica (UK) Limited patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Oxford BioMedica (UK) Limited's patent record in context - here's where to go next.
- Oxford BioMedica (UK) Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #27,063 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Oxford BioMedica (UK) Limited against Opla Energy Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.